Current Topics in Medicinal Chemistry

Editorial [Hot Topic: Targeting Protein Kinases in Drug Discovery and Medicinal Chemistry (Guest Editor: Jeffrey Jie-Lou Liao)]
pp. 1331-1331(1)
Author: Jeffrey, Liao J.i.e-L.o.u.

Molecular Targeting of Protein Kinases to Optimize Selectivity and Resistance Profiles of Kinase Inhibitors
pp. 1332-1335(4)
Author: Jeffrey, Liao J.i.e-L.o.u.

The Role of Halogen Bonding in Inhibitor Recognition and Binding by Protein Kinases
pp. 1336-1348(13)
Authors: Andrea, Voth R.; P., Ho S.h.i.n.g.

Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
pp. 1349-1363(15)
Authors: Craig, Lindsley W.; Stanley, Barnett F.; Melissa, Yaroschak; Mark, Bilodeau T.; Mark, Layton E.

Recent Advances of MEK Inhibitors and Their Clinical Progress
pp. 1364-1378(15)
Authors: John Yuan, Wang; Keith, Wilcoxen M.; Kenichi, Nomoto; Sara, Wu

Molecular Design and Clinical Development of VEGFR Kinase Inhibitors
pp. 1379-1393(15)
Authors: Haizhen, Zhong; J., Bowen P.

Targeting Protein Multiple Conformations: A Structure-Based Strategy for Kinase Drug Design
pp. 1394-1407(14)
Authors: Jeffrey, Liao J.i.e-L.o.u.; Robert, Andrews C.

A Comparison of Physicochemical Property Profiles of Marketed Oral Drugs and Orally Bioavailable Anti-Cancer Protein Kinase Inhibitors in Clinical Development
pp. 1408-1422(15)
Authors: Adrian, Gill L.; Marcel, Verdonk; Robert, Boyle G.; Richard, Taylor

Molecule of the Month
pp. 1423-1423(1)
Author: J., Shotwell B.